Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4
Authors
Keywords
Tamoxifen resistance, miR-10b, HDAC4, ER-positive breast cancers
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-07-23
DOI
10.1186/s12885-015-1561-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer
- (2014) E. A. Reijm et al. ANNALS OF ONCOLOGY
- Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
- (2014) Yifang Wei et al. BREAST CANCER RESEARCH AND TREATMENT
- Critical role of miR-10b in transforming growth factor-β1-induced epithelial–mesenchymal transition in breast cancer
- (2014) Xu Han et al. CANCER GENE THERAPY
- Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
- (2014) R Gan et al. CANCER GENE THERAPY
- MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
- (2014) Aoife Ward et al. JOURNAL OF PATHOLOGY
- Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis
- (2014) Claudia Palena et al. JNCI-Journal of the National Cancer Institute
- Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells
- (2014) CHUTIMA KAEWPIBOON et al. Molecular Medicine Reports
- Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression
- (2014) Zhen-Hua Kang et al. PLoS One
- Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells
- (2014) Lorenzo Colarossi et al. Proteomics Clinical Applications
- Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate
- (2013) Diego Raffo et al. BREAST CANCER RESEARCH AND TREATMENT
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
- (2013) Reiner Hoppe et al. EUROPEAN JOURNAL OF CANCER
- Response of CD44+/CD24−/low breast cancer stem/progenitor cells to tamoxifen- and doxorubicin-induced autophagy
- (2013) VILDAN BETUL YENIGUN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Oncogenic effects of miR-10b in glioblastoma stem cells
- (2013) Fadila Guessous et al. JOURNAL OF NEURO-ONCOLOGY
- AKT-Induced Tamoxifen Resistance Is Overturned by RRM2 Inhibition
- (2013) Khyati N. Shah et al. MOLECULAR CANCER RESEARCH
- Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells
- (2013) SEONG-LAN YU et al. ONCOLOGY REPORTS
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
- (2013) Tissa T. Manavalan et al. PLoS One
- Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions
- (2013) Constantinos Giaginis et al. TUMOR BIOLOGY
- MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells
- (2012) Naohiro Nishida et al. ANNALS OF SURGICAL ONCOLOGY
- CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
- (2012) A Dubrovska et al. BRITISH JOURNAL OF CANCER
- Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
- (2012) B. Ramaswamy et al. CANCER RESEARCH
- Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism
- (2012) Sherif A. Ibrahim et al. INTERNATIONAL JOURNAL OF CANCER
- Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
- (2012) A Ward et al. ONCOGENE
- Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
- (2012) Dejuan Kong et al. PLoS One
- Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
- (2012) Günter Niegisch et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
- (2011) E. A. Stronach et al. CANCER RESEARCH
- Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells
- (2011) A. Ahmad et al. CANCER RESEARCH
- Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
- (2011) Chiara Foroni et al. CANCER TREATMENT REVIEWS
- Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
- (2011) Diana M Cittelly et al. Molecular Cancer
- Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
- (2011) Matthias Port et al. Molecular Cancer
- Unknown
- (2011) Yingchun Zhao et al. MOLECULAR MEDICINE
- Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
- (2011) A Bergamaschi et al. ONCOGENE
- Mechanisms of Endocrine Resistance in Breast Cancer
- (2010) C. Kent Osborne et al. Annual Review of Medicine
- Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
- (2010) Diana M. Cittelly et al. CARCINOGENESIS
- Implication of microRNAs in drug resistance for designing novel cancer therapy
- (2010) Fazlul H. Sarkar et al. DRUG RESISTANCE UPDATES
- Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay
- (2010) Nic Waddell et al. JOURNAL OF PATHOLOGY
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells
- (2009) Mi Ra Kim et al. CANCER SCIENCE
- Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
- (2009) B Song et al. ONCOGENE
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More